CG Oncology (CGON) Other Gross PP&E Adjustments (2023 - 2025)
Historic Other Gross PP&E Adjustments for CG Oncology (CGON) over the last 3 years, with Q3 2025 value amounting to $11.7 million.
- CG Oncology's Other Gross PP&E Adjustments rose 435672.73% to $11.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.7 million, marking a year-over-year increase of 435672.73%. This contributed to the annual value of $138000.0 for FY2024, which is 13270.14% up from last year.
- Per CG Oncology's latest filing, its Other Gross PP&E Adjustments stood at $11.7 million for Q3 2025, which was up 435672.73% from -$965000.0 recorded in Q2 2025.
- CG Oncology's Other Gross PP&E Adjustments' 5-year high stood at $11.7 million during Q3 2025, with a 5-year trough of -$1.0 million in Q1 2025.
- Over the past 3 years, CG Oncology's median Other Gross PP&E Adjustments value was -$348500.0 (recorded in 2024), while the average stood at $1.1 million.
- Over the last 5 years, CG Oncology's Other Gross PP&E Adjustments had its largest YoY gain of 435672.73% in 2025, and its largest YoY loss of 19331.31% in 2025.
- CG Oncology's Other Gross PP&E Adjustments (Quarter) stood at -$422000.0 in 2023, then surged by 132.7% to $138000.0 in 2024, then skyrocketed by 8382.61% to $11.7 million in 2025.
- Its last three reported values are $11.7 million in Q3 2025, -$965000.0 for Q2 2025, and -$1.0 million during Q1 2025.